These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
945 related articles for article (PubMed ID: 14970312)
21. Impacts of aging and amyloid-β deposition on plasminogen activators and plasminogen activator inhibitor-1 in the Tg2576 mouse model of Alzheimer's disease. Bi Oh S; Suh N; Kim I; Lee JY Brain Res; 2015 Feb; 1597():159-67. PubMed ID: 25454795 [TBL] [Abstract][Full Text] [Related]
22. Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression. Manczak M; Anekonda TS; Henson E; Park BS; Quinn J; Reddy PH Hum Mol Genet; 2006 May; 15(9):1437-49. PubMed ID: 16551656 [TBL] [Abstract][Full Text] [Related]
23. Perturbation of sphingolipid metabolism and ceramide production in HIV-dementia. Haughey NJ; Cutler RG; Tamara A; McArthur JC; Vargas DL; Pardo CA; Turchan J; Nath A; Mattson MP Ann Neurol; 2004 Feb; 55(2):257-67. PubMed ID: 14755730 [TBL] [Abstract][Full Text] [Related]
24. Vitamin E as an antioxidant/free radical scavenger against amyloid beta-peptide-induced oxidative stress in neocortical synaptosomal membranes and hippocampal neurons in culture: insights into Alzheimer's disease. Butterfield DA; Koppal T; Subramaniam R; Yatin S Rev Neurosci; 1999; 10(2):141-9. PubMed ID: 10658956 [TBL] [Abstract][Full Text] [Related]
25. Aging, gender and APOE isotype modulate metabolism of Alzheimer's Abeta peptides and F-isoprostanes in the absence of detectable amyloid deposits. Yao J; Petanceska SS; Montine TJ; Holtzman DM; Schmidt SD; Parker CA; Callahan MJ; Lipinski WJ; Bisgaier CL; Turner BA; Nixon RA; Martins RN; Ouimet C; Smith JD; Davies P; Laska E; Ehrlich ME; Walker LC; Mathews PM; Gandy S J Neurochem; 2004 Aug; 90(4):1011-8. PubMed ID: 15287908 [TBL] [Abstract][Full Text] [Related]
26. Oxidative modification of brain proteins in Alzheimer's disease: perspective on future studies based on results of redox proteomics studies. Sultana R; Butterfield DA J Alzheimers Dis; 2013; 33 Suppl 1():S243-51. PubMed ID: 22683528 [TBL] [Abstract][Full Text] [Related]
27. Intracellular amyloid-β accumulation in calcium-binding protein-deficient neurons leads to amyloid-β plaque formation in animal model of Alzheimer's disease. Moon M; Hong HS; Nam DW; Baik SH; Song H; Kook SY; Kim YS; Lee J; Mook-Jung I J Alzheimers Dis; 2012; 29(3):615-28. PubMed ID: 22269161 [TBL] [Abstract][Full Text] [Related]
28. Interaction between 24-hydroxycholesterol, oxidative stress, and amyloid-β in amplifying neuronal damage in Alzheimer's disease: three partners in crime. Gamba P; Leonarduzzi G; Tamagno E; Guglielmotto M; Testa G; Sottero B; Gargiulo S; Biasi F; Mauro A; Viña J; Poli G Aging Cell; 2011 Jun; 10(3):403-17. PubMed ID: 21272192 [TBL] [Abstract][Full Text] [Related]
29. Pyruvate prevents the development of age-dependent cognitive deficits in a mouse model of Alzheimer's disease without reducing amyloid and tau pathology. Isopi E; Granzotto A; Corona C; Bomba M; Ciavardelli D; Curcio M; Canzoniero LM; Navarra R; Lattanzio R; Piantelli M; Sensi SL Neurobiol Dis; 2015 Sep; 81():214-24. PubMed ID: 25434488 [TBL] [Abstract][Full Text] [Related]
30. In vivo protection by the xanthate tricyclodecan-9-yl-xanthogenate against amyloid beta-peptide (1-42)-induced oxidative stress. Perluigi M; Joshi G; Sultana R; Calabrese V; De Marco C; Coccia R; Butterfield DA Neuroscience; 2006; 138(4):1161-70. PubMed ID: 16427207 [TBL] [Abstract][Full Text] [Related]
31. Mutations in amyloid precursor protein and presenilin-1 genes increase the basal oxidative stress in murine neuronal cells and lead to increased sensitivity to oxidative stress mediated by amyloid beta-peptide (1-42), HO and kainic acid: implications for Alzheimer's disease. Mohmmad Abdul H; Sultana R; Keller JN; St Clair DK; Markesbery WR; Butterfield DA J Neurochem; 2006 Mar; 96(5):1322-35. PubMed ID: 16478525 [TBL] [Abstract][Full Text] [Related]
33. Membrane cholesterol interferes with neuronal apoptosis induced by soluble oligomers but not fibrils of amyloid-beta peptide. Sponne I; Fifre A; Koziel V; Oster T; Olivier JL; Pillot T FASEB J; 2004 May; 18(7):836-8. PubMed ID: 15001562 [TBL] [Abstract][Full Text] [Related]
34. Astroglial expression of ceramide in Alzheimer's disease brains: a role during neuronal apoptosis. Satoi H; Tomimoto H; Ohtani R; Kitano T; Kondo T; Watanabe M; Oka N; Akiguchi I; Furuya S; Hirabayashi Y; Okazaki T Neuroscience; 2005; 130(3):657-66. PubMed ID: 15590150 [TBL] [Abstract][Full Text] [Related]
35. Behavioral stress accelerates plaque pathogenesis in the brain of Tg2576 mice via generation of metabolic oxidative stress. Lee KW; Kim JB; Seo JS; Kim TK; Im JY; Baek IS; Kim KS; Lee JK; Han PL J Neurochem; 2009 Jan; 108(1):165-75. PubMed ID: 19012747 [TBL] [Abstract][Full Text] [Related]
36. Aβ promotes VDAC1 channel dephosphorylation in neuronal lipid rafts. Relevance to the mechanisms of neurotoxicity in Alzheimer's disease. Fernandez-Echevarria C; Díaz M; Ferrer I; Canerina-Amaro A; Marin R Neuroscience; 2014 Oct; 278():354-66. PubMed ID: 25168729 [TBL] [Abstract][Full Text] [Related]
37. The relationship between cholesterol level and Alzheimer's disease-associated APP proteolysis/Aβ metabolism. Wang C; Shou Y; Pan J; Du Y; Liu C; Wang H Nutr Neurosci; 2019 Jul; 22(7):453-463. PubMed ID: 29325505 [TBL] [Abstract][Full Text] [Related]